Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts-Reference-Cited by-同舟云学术

Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts

Published:2009-11 Issue:11 Volume:39 Page:3121-3133
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Poehlein Christian H.,Haley Daniel P.,Walker Edwin B.,Fox Bernard A.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2;Yoshizawa;J. Immunol.,1991

2. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy;Hu;J. Immunol.,2000

3. Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor;Chang;Hum. Gene Ther.,2000

4. Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancer;Chang;J. Clin. Oncol.,2003

5. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2;Chang;J. Clin. Oncol.,1997

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect;Current Treatment Options in Oncology;2023-04-03

2. High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD);Journal of Cancer Research and Clinical Oncology;2022-09-29

3. Anti-Gr-1 Antibody Provides Short-Term Depletion of MDSC in Lymphodepleted Mice with Active-Specific Melanoma Therapy;Vaccines;2022-04-04

4. Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy;The Journal of Immunology;2021-06-21

5. Paving the Way Towards Universal Chimeric Antigen Receptor Therapy in Cancer Treatment: Current Landscape and Progress;Frontiers in Immunology;2020-12-10